FOXP3 and neoplasm: Accumulations of Tregs in the TME characterized by the expression of the forkhead/winged helix transcription factor (Foxp3) have been reported to promote tumor progression and prognosis, as well as downregulate effective antitumor immune responses in tumor-bearing hosts, thereby deterring tumor immune surveillance [587,588,589].